Inhibitors of protein prenylation 2000

被引：47

作者：

Bell, IM ^{[1
]}

机构：

[1] Merck Res Labs, West Point, PA 19486 USA

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 2000年 / 10卷 / 12期

关键词：

cancer therapy; farnesyltransferase; farnesyltransferase inhibitor; geranylgeranyltransferase; protein prenylation; ras oncogene;

D O I：

10.1517/13543776.10.12.1813

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The development of farnesyltransferase inhibitors (FTIs) was conceived of as a rational approach to the design of new cancer chemotherapeutics and the first examples of this class are currently being evaluated in Phase II and Phase III clinical trials. This review summarises the scientific and patent literature published in the 14 month period from March 1999, since the previous review [1]. In addition to a survey of novel prenyl transferase inhibitors, recent clinical data and developments in related biochemistry and biology are described.

引用

页码：1813 / 1831

页数：19

共 72 条

[1]

ADAMSON P, 1992, J BIOL CHEM, V267, P20033

[2]

Adjei AA, 2000, CANCER RES, V60, P1871

[3]

Adjei AA, 2000, CLIN CANCER RES, V6, P2318

[4] Analogues of 1-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo-[5,6]-cyclohepta[1,2-b]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase [J].

Afonso, A ;

Weinstein, J ;

Kelly, J ;

Wolin, R ;

Rosenblum, SB ;

Connolly, M ;

Guzi, T ;

James, L ;

Carr, D ;

Patton, R ;

Bishop, WR ;

Kirshmeier, P ;

Liu, M ;

Heimark, L ;

Chen, KJ ;

Nomeir, AA .

BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) :1845-1855

[5] Guanosine triphosphatase stimulation of oncogenic Ras mutants [J].

Ahmadian, MR ;

Zor, T ;

Vogt, D ;

Kabsch, W ;

Selinger, Z ;

Wittinghofer, A ;

Scheffzek, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :7065-7070

[6]

ANDRES DA, 1993, J BIOL CHEM, V268, P1383

[7] Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase [J].

Anthony, NJ ;

Gomez, RP ;

Schaber, MD ;

Mosser, SD ;

Hamilton, KA ;

O'Neil, TJ ;

Koblan, KS ;

Graham, SL ;

Hartman, GD ;

Shah, D ;

Rands, E ;

Kohl, NE ;

Gibbs, JB ;

Oliff, AI .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) :3356-3368

[8]

ASHAR HR, 2000, P AM ASSOC CANC RES, V41, P219

[9]

Bernhard EJ, 1998, CANCER RES, V58, P1754

[10] Conformation of a novel tetrapeptide inhibitor NH2-D-Trp-D-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase [J].

Bogusky, MJ ;

Culberson, JC ;

Pitzenberger, SM ;

Garsky, VM ;

Wallace, A ;

Pessi, A ;

Koblan, KS .

JOURNAL OF PEPTIDE RESEARCH, 1999, 54 (01) :66-73

← 1 2 3 4 5 6 7 8 →